Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Preparing Your Medical Device for Market: Seasonal Considerations

Jul 10, 2026By Sreejith Kanhirangadan

SK

Understanding Seasonal Demand

When preparing your medical device for market, it's crucial to consider seasonal demand. Different times of the year can affect the need and urgency for specific medical devices. For example, flu season typically increases the demand for respiratory-related devices. Understanding these patterns can help you optimize your product launch and marketing strategies.

medical device calendar

Regulatory Timelines and Holidays

Navigating regulatory approvals is a critical step in bringing a medical device to market. It's essential to account for seasonal slowdowns, such as holidays, which can affect timelines. Regulatory bodies often experience delays during major holidays, so plan your submissions accordingly.

Consider creating a timeline that includes potential delays to ensure that your launch is not unexpectedly postponed. Being aware of these factors can help you set realistic expectations and maintain a smooth process.

Supply Chain and Production

The season can greatly impact your supply chain and production capabilities. Winter weather, for instance, can disrupt transportation and delay shipments, while summer vacations can lead to workforce shortages.

supply chain management

To mitigate these risks, work closely with your suppliers to develop contingency plans. This might include stocking up on critical components or finding alternative transport routes to ensure that your production schedule remains on track.

Marketing Strategies

Seasonal considerations should also influence your marketing strategies. Tailor your messaging to reflect the current season and its specific health concerns. For instance, promoting allergy relief devices in spring can resonate well with consumers.

  • Align your promotional campaigns with seasonal health trends.
  • Utilize seasonal imagery and themes in your advertisements.
  • Plan special offers around holidays to boost sales.
marketing strategy

Customer Engagement

Engaging with your customers seasonally can enhance your brand's visibility and relevance. Consider hosting webinars or informational sessions that address seasonal health issues and demonstrate how your devices can provide solutions.

Additionally, leverage social media platforms to interact with your audience. Share tips and insights related to seasonal health challenges and encourage users to share their experiences with your products.

Forecasting and Inventory Management

Accurate forecasting is vital to ensure that you have the right amount of inventory to meet seasonal demand. Use historical data to predict trends and adjust your inventory levels accordingly. This helps in avoiding overproduction or stockouts, both of which can impact profitability.

Implementing a flexible inventory management system can allow for quick adjustments in response to unexpected changes in demand.

inventory management

Conclusion

Preparing your medical device for market requires comprehensive planning, especially when considering seasonal factors. By understanding demand patterns, navigating regulatory timelines, managing the supply chain, crafting effective marketing strategies, and engaging with customers, you can position your product for success throughout the year.

With the right strategies in place, you'll be well-equipped to navigate the complexities of bringing a medical device to market, ensuring both compliance and customer satisfaction.